Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.
- Published In:
- Nature medicine, 31(10), 3294-3296 (2025)
- Authors:
- Bhatnagar, Pallav, Ahmad, Nadia N(3), Li, Xuan(2), Coghlan, Matthew, Kaplan, Lee M, Farooqi, I Sadaf
- Database ID:
- RPEP-10150
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10150APA
Bhatnagar, Pallav; Ahmad, Nadia N; Li, Xuan; Coghlan, Matthew; Kaplan, Lee M; Farooqi, I Sadaf. (2025). Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.. Nature medicine, 31(10), 3294-3296. https://doi.org/10.1038/s41591-025-03913-2
MLA
Bhatnagar, Pallav, et al. "Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency.." Nature medicine, 2025. https://doi.org/10.1038/s41591-025-03913-2
RethinkPeptides
RethinkPeptides Research Database. "Tirzepatide leads to weight reduction in people with obesity..." RPEP-10150. Retrieved from https://rethinkpeptides.com/research/bhatnagar-2025-tirzepatide-leads-to-weight
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.